The immunology of Epstein-Barr virus–induced disease

GS Taylor, HM Long, JM Brooks… - Annual review of …, 2015 - annualreviews.org
Epstein-Barr virus (EBV) is usually acquired silently early in life and carried thereafter as an
asymptomatic infection of the B lymphoid system. However, many circumstances disturb the …

The tumour microenvironment in B cell lymphomas

DW Scott, RD Gascoyne - Nature Reviews Cancer, 2014 - nature.com
B cell lymphomas are cancers that arise from cells that depend on numerous highly
orchestrated interactions with immune and stromal cells in the course of normal …

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

C Steidl, T Lee, SP Shah, P Farinha… - … England Journal of …, 2010 - Mass Medical Soc
Background Despite advances in treatments for Hodgkin's lymphoma, about 20% of patients
still die from progressive disease. Current prognostic models predict the outcome of …

Phase II investigator-initiated study of brentuximab vedotin in mycosis fungoides and Sézary syndrome with variable CD30 expression level: a multi-institution …

YH Kim, M Tavallaee, U Sundram, KA Salva… - Journal of Clinical …, 2015 - ascopubs.org
Purpose In contrast to Hodgkin lymphoma and systemic anaplastic large-cell lymphoma,
CD30 expression of malignant lymphocytes in mycosis fungoides (MF) and Sézary …

Hodgkin lymphoma

JM Connors, W Cozen, C Steidl, A Carbone… - Nature Reviews …, 2020 - nature.com
Hodgkin lymphoma (HL) is a B cell lymphoma characterized by few malignant cells and
numerous immune effector cells in the tumour microenvironment. The incidence of HL is …

Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment

C Steidl, JM Connors, RD Gascoyne - Journal of Clinical Oncology, 2011 - ascopubs.org
Hodgkin's lymphoma (HL) represents the most common subtype of malignant lymphoma in
young people in the Western world. Most patients can be cured with modern treatment …

Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors

K Milne, M Köbel, SE Kalloger, RO Barnes, D Gao… - PloS one, 2009 - journals.plos.org
Background Tumor-infiltrating T cells are associated with survival in epithelial ovarian
cancer (EOC), but their functional status is poorly understood, especially relative to the …

Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review

R Camicia, HC Winkler, PO Hassa - Molecular cancer, 2015 - Springer
Diffuse large B-cell lymphoma (DLBCL) is a clinically heterogeneous lymphoid malignancy
and the most common subtype of non-Hodgkin's lymphoma in adults, with one of the highest …

The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape

D Aldinucci, A Gloghini, A Pinto… - The Journal of …, 2010 - Wiley Online Library
It has become clear that cancer is not merely a growth of autonomously proliferating cells,
but that other non‐malignant cell types are a functional part of the disease. Immune cells …

Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial

KL Tan, DW Scott, F Hong, BS Kahl… - Blood, The Journal …, 2012 - ashpublications.org
Increased tumor-associated macrophages (TAMs) are reported to be associated with poor
prognosis in classic Hodgkin lymphoma (CHL). We investigated the prognostic significance …